Bleeding and Myocardial Infarction in Acquired Factor VIII Deficiency

HomeCirculationVol. 148, No. 14Bleeding and Myocardial Infarction in Acquired Factor VIII Deficiency No AccessCase ReportRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessCase ReportRequest AccessFull TextBleeding and Myocardial Infarction in Acquired Factor VIII Deficiency Joseph M. Kim, Robert M. Stern and Bradley A. Maron Joseph M. KimJoseph M. Kim https://orcid.org/0000-0003-1584-3927 Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (J.M.K.). Harvard Medical School, Boston, MA (J.M.K., R.M.S., B.A.M.). , Robert M. SternRobert M. Stern Harvard Medical School, Boston, MA (J.M.K., R.M.S., B.A.M.). Divisions of Hematology (R.M.S.), Brigham and Women's Hospital, Boston, MA. and Bradley A. MaronBradley A. Maron Correspondence to: Bradley A. Maron, MD, University of Maryland School of Medicine, 655 W. Baltimore St, Baltimore, MD 21201. Email E-mail Address: [email protected] https://orcid.org/0000-0002-6784-764X Harvard Medical School, Boston, MA (J.M.K., R.M.S., B.A.M.). Cardiovascular Medicine (B.A.M.), Brigham and Women's Hospital, Boston, MA. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD and the University of Maryland-Institute for Health Computing, Bethesda, MD (B.A.M.). Originally published2 Oct 2023https://doi.org/10.1161/CIRCULATIONAHA.123.063904Circulation. 2023;148:1127–1133FootnotesFor Sources of Funding and Disclosures, see page 1133.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Bradley A. Maron, MD, University of Maryland School of Medicine, 655 W. Baltimore St, Baltimore, MD 21201. Email BMaron@som.umaryland.eduREFERENCES1. Pishko AM, Doshi BS. Acquired hemophilia A: current guidance and experience from clinical practice.J Blood Med. 2022; 13:255–265. doi: 10.2147/JBM.S284804CrossrefMedlineGoogle Scholar2. Knoebl P, Thaler J, Jilma P, Quehenberger P, Gleixner K, Sperr WR. Emicizumab for the treatment of acquired hemophilia A.Blood. 2021; 137:410–419. doi: 10.1182/blood.2020006315CrossrefMedlineGoogle Scholar3. Siddiqui HF, Ejaz T, Siddiqui AF, Shaikh FN. Acquired hemophilia A: a possibly fatal complication of SARS-COV-2 infection.Ann Med Surg. 2022; 80:104275. doi: 10.1016/j.amsu.2022.104275CrossrefMedlineGoogle Scholar4. Martin K, Key NS. How I treat patients with inherited bleeding disorders who need anticoagulant therapy.Blood. 2016; 128:178–184. doi: 10.1182/blood-2015-12-635094CrossrefMedlineGoogle Scholar5. Staritz P, de Moerloose P, Schutgens R, Dolan G; ADVANCE Working Group. Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group.Haemophilia. 2013; 19:833–840. doi: 10.1111/hae.12189CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails October 3, 2023Vol 148, Issue 14 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.123.063904PMID: 37782697 Originally publishedOctober 2, 2023 Keywordsacute coronary syndromePDF download Advertisement SubjectsAnticoagulantsCardiovascular SurgeryPacemakerRevascularization